Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Petit

Sports Medicine Lake Oswego, OR Medical Doctor

NPI 1356332720 CMS profile 15543

17355 Lower Boones Ferry Rd, #100A, Lake Oswego, OR 97035

Open in the dashboard

General payments

$61,282

116 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Petit of Lake Oswego, OR is reported in the CMS Open Payments database as having received $61,282 across 116 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $245 7
2024 General $1,087 8
2023 General $13,038 18
2022 General $14,534 20
2021 General $27,254 44
2020 General $988 4
2019 General $4,136 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Petit
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Charles Petit were reported at $245. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Charles Petit Sports Medicine median Middle half National median
2019 $4,136 $1,176 $199–$4,249 $163
2020 $988 $708 $96–$2,890 $114
2021 $27,254 $1,213 $152–$3,994 $132
2022 $14,534 $1,230 $159–$3,998 $149
2023 $13,038 $584 $146–$2,836 $160
2024 $1,087 $628 $163–$3,168 $164
2025 $245 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $40,568 67 payments
  2. Vericel Corporation $15,647 14 payments
  3. Acumed LLC $2,639 8 payments
  4. Steelhead Surgical Inc $1,364 3 payments
  5. Miach Orthopaedics, Inc. $274 2 payments
  6. Shoulder Innovations, Inc. $186 3 payments
  7. Stryker Corporation $167 3 payments
  8. Smith+Nephew, Inc. $124 5 payments
  9. Arthrex, Inc. $67 1 payment
  10. Ethicon US, LLC $61 2 payments
  11. Other $185 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $45,410 30 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $8,000 3 payments
  3. Travel and Lodging $3,342 32 payments
  4. Food and Beverage $2,413 47 payments
  5. Education $1,466 3 payments
  6. Honoraria $650 1 payment
Products named General payments · program years 2019–2025
  1. Comprehensive Anatomic $17,230 15 payments
  2. MACI $15,410 12 payments
  3. Comprehensive Reverse $14,821 16 payments
  4. Comprehensive Shoulder System $10,170 12 payments
  5. Signature Glenoid Guides $4,099 4 payments
  6. Delta $3,000 1 payment
  7. Extremities Product Portfolio $2,688 5 payments
  8. Comprehensive Primary Stem $1,405 16 payments
  9. Acu-Loc Wrist Plating System $933 1 payment
  10. Cannulated Screw System $858 5 payments
  11. Other $2,732 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

312

Median for Sports Medicine: 144

Drug cost

$1,772

Median for Sports Medicine: $1,027

Branded share of claims

11.5%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 72 $447
Ondansetron Hcl Generic 32 $348
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 36 $271
Mupirocin Generic 27 $203
Gabapentin Generic 13 $134
Hydromorphone Hcl Generic 16 $115
Amoxicillin Generic 60 $72
Methocarbamol Generic 13 $59
Cephalexin Generic 15 $47
Tramadol Hcl Generic 14 $39

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$173,094

Of which drugs: $4,769

Medicare patients

360

Average age 72

Services billed

2,123

207 women, 153 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 56%
Depression 20%
Osteoporosis 18%
Ischemic heart disease 15%
Cancer 15%
Diabetes 14%
Atrial fibrillation 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 125 207 $156
Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 Office 29 34 $1

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record